Diabetes Drugs Avandia, Actos Linked to Vision Woes

<p>MONDAY, Jun 11 (HealthDay News) — British researchers report
that <span>thiazolidinediones</span>, <span>diabetes medications</span> that are used to help
control <span>blood sugarine levels</span>, might means eye problems in those who take
them.</p>
<p>The drugs that tumble into this organisation embody Avandia and Actos, which
have been tied to increasing risk of heart conflict in a box of Avandia
and bladder cancer in a box of Actos. Now it is probable that these
drugs might also means <span>diabetic macular edema</span>, a investigate authors said.</p>
<p>“Patients who perceived a thiazolidinedione were during two- to three-fold
increased risk of building <span>macular edema</span>,” pronounced lead researcher Dr.
Iskandar Idris, an associate highbrow in diabetes medicine during the
University of Nottingham.</p>
<p>However, a risk of macular edema is really small, about 0.2 per...